- $2.22bn
- $2.55bn
- $223.81m
- 70
- 22
- 41
- 41
2019 December 31st | 2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 132 | 128 | 124 | 149 | 224 |
Cost of Revenue | |||||
Gross Profit | 78.1 | 79.8 | 72.3 | 83.5 | 154 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 196 | 188 | 187 | 367 | 234 |
Operating Profit | -63.9 | -59.2 | -62.4 | -218 | -10.6 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 15.9 | -109 | -113 | -257 | -23.6 |
Provision for Income Taxes | |||||
Net Income After Taxes | 15.3 | -110 | -113 | -257 | -24.7 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 15.3 | -110 | -113 | -257 | -24.7 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 15.3 | -110 | -113 | -258 | -35.3 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.01 | -0.067 | -0.065 | -0.084 | -0.014 |